HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Giorgio, A. Articles by Ferraioli, G. Search for Related Content PubMed PubMed Citation Articles by Giorgio, A. Articles by Ferraioli, G. Social Bookmarking                      What's this? Hotlight (NEW!) What's Hotlight?

Percutaneous Sonographically Guided Saline-Enhanced Radiofrequency Ablation of Hepatocellular Carcinoma

¹ All authors: Interventional Ultrasound Service, D. Cotugno Hospital, Viale Colli Aminei 491, Naples 80131, Italy.

OBJECTIVE. The purpose of our study was to analyze the efficacy, side effects, and short-term complications of saline-enhanced percutaneous radiofrequency ablation performed under sonographic guidance in a series of cirrhotic patients with hepatocellular carcinoma.

SUBJECTS AND METHODS. Between September 2000 and June 2002, 84 patients (55 men and 29 women) with cirrhosis who ranged in age from 48 to 74 years (mean age, 64 years) and who had 95 hepatocellular carcinomas (seven patients had two tumors and two patients had three tumors) were treated with high frequency–induced thermotherapy. The diameters of the tumors ranged from 1.5 to 8.5 cm (mean, 3.6 cm). The efficacy of radiofrequency ablation was evaluated with triphasic contrast-enhanced CT performed 4 weeks after the procedure.

RESULTS. Posttreatment CT showed complete necrosis in 73 (77%) of 95 hepatocellular carcinomas in 62 patients. Complete necrosis based on tumor size was seen in 40 (95%) of 42 tumors with diameters equal to or smaller than 3 cm, 32 (71%) of 45 tumors with diameters between 3.1 and 5.0 cm, and one (12%) of eight tumors with diameters larger than 5.0 cm. Twenty-two hepatocellular carcinomas showed incomplete necrosis. None of the patients experienced major complications. Four patients were lost to follow-up. The length of the follow-up period ranged from 4 to 22 months (mean, 10 months). One patient died 8 months after the radiofrequency ablation treatment. All the remaining patients are still alive. During the follow-up period, eight (10%) of 80 patients showed a local recurrence on sonography and CT.

CONCLUSION. Our experience suggests that percutaneous radiofrequency ablation of hepatocellular carcinoma with high frequency–induced thermotherapy is safe and effective in the treatment of hepatocellular carcinomas equal to or smaller than 3 cm, fairly effective for hepatocellular carcinomas between 3 and 5 cm, and ineffective for tumors larger than 5 cm.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Giorgio, A. Di Sarno, G. de Stefano, N. Farella, U. Scognamiglio, M. de Stefano, and V. Giorgio Hepatocellular Carcinoma With Cirrhosis: Are Patients With Neoplastic Main Portal Vein Invasion Eligible for Percutaneous Radiofrequency Ablation of Both the Nodule and the Portal Venous Tumor Thrombus? Am. J. Roentgenol., October 1, 2009; 193(4): 948 - 954. [Abstract] [Full Text] [PDF]

				T. Shibata, H. Isoda, Y. Hirokawa, S. Arizono, K. Shimada, and K. Togashi Small Hepatocellular Carcinoma: Is Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization More Effective than Radiofrequency Ablation Alone for Treatment? Radiology, September 1, 2009; 252(3): 905 - 913. [Abstract] [Full Text] [PDF]

				F. Tatsugami, M. Matsuki, G. Nakai, M. Tanikake, S. Yoshikawa, I. Narabayashi, K. Miyaji, A. Asai, S. Fujiwara, Y. Hongo, et al. Hepatic Computed Tomography for Simultaneous Depiction of Hepatocellular Carcinoma, Intrahepatic Portal Veins, and Hepatic Veins in Real-time Virtual Sonography: Initial Experience J. Ultrasound Med., August 1, 2007; 26(8): 1065 - 1069. [Abstract] [Full Text] [PDF]

				Y. Minami, M. Kudo, H. Chung, T. Kawasaki, Y. Yagyu, T. Shimono, and H. Shiozaki Contrast Harmonic Sonography-Guided Radiofrequency Ablation Therapy Versus B-Mode Sonography in Hepatocellular Carcinoma: Prospective Randomized Controlled Trial Am. J. Roentgenol., February 1, 2007; 188(2): 489 - 494. [Abstract] [Full Text] [PDF]

				M. Hirooka, H. Iuchi, T. Kumagi, S. Shigematsu, A. Hiraoka, T. Uehara, K. Kurose, N. Horiike, and M. Onji Virtual Sonographic Radiofrequency Ablation of Hepatocellular Carcinoma Visualized on CT but Not on Conventional Sonography. Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S255 - S260. [Abstract] [Full Text] [PDF]

				T. Shibata, T. Shibata, Y. Maetani, H. Isoda, and M. Hiraoka Radiofrequency Ablation for Small Hepatocellular Carcinoma: Prospective Comparison of Internally Cooled Electrode and Expandable Electrode Radiology, January 1, 2006; 238(1): 346 - 353. [Abstract] [Full Text] [PDF]

				J. M. Lee, J. K. Han, S. H. Kim, S. H. Choi, S. K. An, C. J. Han, and B. I. Choi Bipolar Radiofrequency Ablation Using Wet-Cooled Electrodes: An In Vitro Experimental Study in Bovine Liver Am. J. Roentgenol., February 1, 2005; 184(2): 391 - 397. [Abstract] [Full Text] [PDF]

				A. Giorgio, L. Tarantino, G. de Stefano, C. Coppola, and G. Ferraioli Complications After Percutaneous Saline-Enhanced Radiofrequency Ablation of Liver Tumors: 3-Year Experience with 336 Patients at a Single Center Am. J. Roentgenol., January 1, 2005; 184(1): 207 - 211. [Abstract] [Full Text] [PDF]